Composition and method for treating cancer
US5618831A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | May 16, 1994 |
| Grant date | Apr 8, 1997 |
| Priority date | — |
| Expiry date | May 16, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/506
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for treatment of cancer in an animal comprising: (A) a therapeutically effective amount of at least one compound selected from the group consisting of compounds represented by the General Formula (I). ##STR1## wherein Z.sub.1 and Z.sub.2, which may be the same or different, each represents an atomic group necessary to form a 5- or 6-membered ring; R.sub.1, R.sub.2 and R.sub.3, which may be the same or different, each represents an alkyl group or an aryl group; L.sub.1 and L.sub.2 each represents a methine group or a substituted methine group; X represents a pharmaceutically acceptable anion; k represents a number necessary for electrical charge balance; n represents 0 or 1; and (B) a pharmaceutically acceptable carrier or diluent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.